Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart G Baker

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Statistics in Medicine|March 13, 2018
Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trialsStuart G Baker
Journal of the National Cancer Institute|May 10, 2015
Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerStuart G Baker
Medical Hypotheses|August 8, 2020
Rethinking carcinogenesis: The detached pericyte hypothesisStuart G Baker
Journal of the National Cancer Institute|March 14, 2015
ResponseStuart G Baker
Statistics in Medicine|January 24, 2013
Remarks on 'A simple decision analytic solution to the comparison of two binary diagnostic tests' by Vickers et alStuart G Baker
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 15, 2011
TOFT better explains experimental results in cancer research than SMT (comment on DOI 10.1002/bies.201100025 and DOI 10.1002/bies.201100022)Stuart G Baker
Biometrics|December 17, 2013
Letter to the editor: "Comment on Hubbard and Miglioretti (2013), consider also a selection model for the cumulative risk of false positive screening tests"Stuart G Baker
Carcinogenesis|June 15, 2021
The case for a cancer paradox initiativeStuart G Baker
Statistics in Medicine|August 9, 2019
Maximum likelihood estimation with missing outcomes: From simplicity to complexityStuart G Baker
Clinical Trials (London, England)|May 22, 2014
Principal stratification: All-or-none versus partial complianceStuart G Baker
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Statistics in Medicine|March 13, 2018
Five criteria for using a surrogate endpoint to predict treatment effect based on data from multiple previous trialsStuart G Baker
Journal of the National Cancer Institute|May 10, 2015
Re: Combined associations of genetic and environmental risk factors: implications for prevention of breast cancerStuart G Baker
Medical Hypotheses|August 8, 2020
Rethinking carcinogenesis: The detached pericyte hypothesisStuart G Baker
Journal of the National Cancer Institute|March 14, 2015
ResponseStuart G Baker
Statistics in Medicine|January 24, 2013
Remarks on 'A simple decision analytic solution to the comparison of two binary diagnostic tests' by Vickers et alStuart G Baker
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|October 15, 2011
TOFT better explains experimental results in cancer research than SMT (comment on DOI 10.1002/bies.201100025 and DOI 10.1002/bies.201100022)Stuart G Baker
Biometrics|December 17, 2013
Letter to the editor: "Comment on Hubbard and Miglioretti (2013), consider also a selection model for the cumulative risk of false positive screening tests"Stuart G Baker
Carcinogenesis|June 15, 2021
The case for a cancer paradox initiativeStuart G Baker
Statistics in Medicine|August 9, 2019
Maximum likelihood estimation with missing outcomes: From simplicity to complexityStuart G Baker
Clinical Trials (London, England)|May 22, 2014
Principal stratification: All-or-none versus partial complianceStuart G Baker
Pageof 12